A 68-year-old man with histologically confirmed localized prostate cancer (Gleason score 7, PSA 12 ng/mL) and no distant metastases is counselled for androgen deprivation therapy (ADT) as part of multimodal treatment. Which drug is the first-line choice for long-term hormonal suppression in this patient?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.